GLP-1 Weight Loss for Insulin Resistance and Metabolic Health Many patients interested in GLP-1 therapy also struggle with insulin resistance, prediabetes, type 2 diabetes risk, abdominal weight gain, cravings, fatigue after meals, or difficulty losing weight despite eating less
Clinical Research The Westlake Dermatology Clinical Research Center contributes to the advancement of treatments and therapies in the fields of clinical, cosmetic, and laser dermatology
Yes, PT-141 (bremelanotide) is legally available through prescription in the United States
Adherence, persistence, glycaemic control and costs among patients with type 2 diabetes initiating dulaglutide compared with liraglutide or exenatide once weekly at 12-month follow-up in a real-world setting in the United States